Acute psychosis related to use of trimethoprim/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study
Author(s) -
K.-Y. Lee,
ChiHsiang Huang,
H.-J. Tang,
ChiaJui Yang,
WenChien Ko,
YenHsu Chen,
YiChung Lee,
ChienChing Hung
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks283
Subject(s) - trimethoprim , sulfamethoxazole , medicine , pneumonia , incidence (geometry) , retrospective cohort study , pneumocystis pneumonia , pneumocystis jirovecii , psychosis , antibiotics , psychiatry , microbiology and biotechnology , physics , optics , biology
A recent study reported that trimethoprim/sulfamethoxazole caused acute psychosis in four renal transplant patients with Pneumocystis jirovecii pneumonia. We aimed to investigate the incidence of and factors associated with trimethoprim/sulfamethoxazole-related acute psychosis in HIV-infected patients with P. jirovecii pneumonia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom